← Back to headlines





KMI partners with Guardant Health on liquid biopsy cancer screening
The Korea Medical Institute said Tuesday it has signed a memorandum of understanding with US-based Guardant Health to collaborate on liquid biopsy-based precision cancer screening.
12 Mar, 05:09 — 12 Mar, 05:09
Related Stories

Irish Health Agency Fined €645,000 for Storing Records in Derelict Sites
1h ago

New Urine Test Detects Over 90 Percent of Bladder Cancer Cases
2h ago

Swimmer Hospitalized Following Suspected Shark Attack in Massachusetts
5h ago

Wellington Clinics Suspends Kidney Transplants Amid Organ Harvesting Probe
11h ago